Friday 6 November 2026
Export CHE’s income statement to Excel — free account
Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
526.19
7.58
−1.42%
Follow CHE
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
7 | 5 | 5 | 6 |
+8 more TTM periods Free account |
| 29.14% | 27.11% | 25.60% | 25.28% | ||
| 16.90% | 16.68% | 15.93% | 16.54% | ||
ROIC |
22.10% | 23.46% | 22.23% | 23.36% | |
Return on Tangible Assets |
112.17% | 152.87% | 161.98% | 119.94% | |
Average Days of Receivables |
34.96 | 26.53 | 30.96 | 26.34 | |
Free Cash Flow per Share |
22.73 | 24.91 | 27.91 | 22.92 | |
Free Cash Flow |
296.76 | 328.12 | 381.71 | 330.05 | |
Capital Expenditures |
(66.40) | (61.84) | (62.04) | (58.23) | |
| Other line items | |||||
Cash ROIC |
25.90% | 32.46% | 39.93% | 31.32% | |
Accounts Receivable Turnover |
11.31 | 13.90 | 10.13 | 14.30 | |
Accounts Payable Turnover |
31.19 | 25.60 | 30.30 | 31.43 | |
Inventory Turnover |
221.26 | 206.90 | 229.10 | 216.93 | |
Average Days of Payables |
13.48 | 17.81 | 13.96 | 13.78 | |
Days of Inventory on Hand |
1.60 | 1.60 | 1.53 | 1.61 | |
Tax Rate |
(0.26) | (0.26) | (0.26) | (0.25) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
16.78% | 16.99% | 16.76% | 16.49% | |
Share Based Compensation of Revenue |
1.55% | 1.46% | 1.44% | 1.48% | |
Interest Coverage |
75.39 | 106.49 | 169.72 | 193.28 | |
Operating CF/Net income |
1.29 | 1.42 | 1.71 | 1.46 | |
Depreciation/Fixed assets |
0.31 | 0.32 | 0.32 | 0.32 | |
Capex/Depreciation |
(0.98) | (0.93) | (0.94) | (0.89) | |
Revenue per Share |
203.79 | 196.98 | 185.78 | 175.72 | |
Operating CF per Share |
27.81 | 29.60 | 32.45 | 26.97 | |
Capex per Share |
(5.08) | (4.69) | (4.54) | (4.04) | |
Capex to Sales |
0.03 | 0.02 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 5 Nov 2026